Literature DB >> 29862310

Alterations in Hippocampal Activity and Alzheimer's Disease.

Sharay E Setti1, Holly C Hunsberger2,3, Miranda N Reed1.   

Abstract

The aging population and those with amnestic mild cognitive impairment (aMCI) are at increased risk for developing Alzheimer's disease (AD). Individuals with aMCI in particular may display pathological changes in brain function that may ultimately result in a diagnosis of AD. This review focuses specifically on hippocampal hyperexcitability, a pathology that is sometimes detectable years before diagnosis, which has been observed in individuals with aMCI. We describe how changes in hippocampal activity are associated with, or in some cases may be permissive for, the development of AD. Finally, we describe how lifestyle changes, including exercise and dietary changes can attenuate cognitive decline and hippocampal hyperexcitability, potentially reducing the risk of developing AD.

Entities:  

Year:  2017        PMID: 29862310      PMCID: PMC5972837          DOI: 10.1037/tps0000124

Source DB:  PubMed          Journal:  Transl Issues Psychol Sci


  66 in total

Review 1.  Collaborative effects of diet and exercise on cognitive enhancement.

Authors:  Fernando Gomez-Pinilla
Journal:  Nutr Health       Date:  2011

Review 2.  Successful aging.

Authors:  J W Rowe; R L Kahn
Journal:  Gerontologist       Date:  1997-08

3.  P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway.

Authors:  Holly C Hunsberger; Carolyn C Rudy; Seth R Batten; Greg A Gerhardt; Miranda N Reed
Journal:  J Neurochem       Date:  2014-10-31       Impact factor: 5.372

Review 4.  Neurocognitive aging: prior memories hinder new hippocampal encoding.

Authors:  Iain A Wilson; Michela Gallagher; Howard Eichenbaum; Heikki Tanila
Journal:  Trends Neurosci       Date:  2006-10-13       Impact factor: 13.837

Review 5.  Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Reisa Sperling
Journal:  Ann N Y Acad Sci       Date:  2007-02       Impact factor: 5.691

6.  Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus.

Authors:  H Kang; E M Schuman
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

7.  Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline.

Authors:  S L Miller; E Fenstermacher; J Bates; D Blacker; R A Sperling; B C Dickerson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09-10       Impact factor: 10.154

Review 8.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

9.  Transmission and spreading of tauopathy in transgenic mouse brain.

Authors:  Florence Clavaguera; Tristan Bolmont; R Anthony Crowther; Dorothee Abramowski; Stephan Frank; Alphonse Probst; Graham Fraser; Anna K Stalder; Martin Beibel; Matthias Staufenbiel; Mathias Jucker; Michel Goedert; Markus Tolnay
Journal:  Nat Cell Biol       Date:  2009-06-07       Impact factor: 28.824

10.  Optogenetic dissection of ictal propagation in the hippocampal-entorhinal cortex structures.

Authors:  Yi Lu; Cheng Zhong; Lulu Wang; Pengfei Wei; Wei He; Kang Huang; Yi Zhang; Yang Zhan; Guoping Feng; Liping Wang
Journal:  Nat Commun       Date:  2016-03-21       Impact factor: 14.919

View more
  14 in total

Review 1.  On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer's Disease.

Authors:  Jan Kriska; Zuzana Hermanova; Tomas Knotek; Jana Tureckova; Miroslava Anderova
Journal:  Int J Mol Sci       Date:  2021-09-07       Impact factor: 6.208

2.  GNG13 Is a Potential Marker of the State of Health of Alzheimer's Disease Patients' Cerebellum.

Authors:  Cristina Sanfilippo; Giuseppe Musumeci; Maria Kazakova; Venera Mazzone; Paola Castrogiovanni; Rosa Imbesi; Michelino Di Rosa
Journal:  J Mol Neurosci       Date:  2020-10-15       Impact factor: 3.444

Review 3.  Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease.

Authors:  Tamara K Stevenson; Shannon J Moore; Geoffrey G Murphy; Daniel A Lawrence
Journal:  Semin Thromb Hemost       Date:  2021-12-23       Impact factor: 6.398

4.  Exercise-Induced Cognitive Improvement Is Associated with Sodium Channel-Mediated Excitability in APP/PS1 Mice.

Authors:  Ya-Xin Tan; Guang-Cai Liu; Hong-Lan Chen; Min-Nan Lu; Bo Chen; Tao Hu; Li Zhang; Rui Mao; Shan Li; Rong Mei; Xu-Yang Wang; Yan-Bin Xiyang
Journal:  Neural Plast       Date:  2020-03-18       Impact factor: 3.599

5.  The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases.

Authors:  Oliwia Koszła; Przemysław Sołek; Sylwia Woźniak; Ewa Kędzierska; Tomasz M Wróbel; Magda Kondej; Aneta Archała; Piotr Stępnicki; Grażyna Biała; Dariusz Matosiuk; Agnieszka A Kaczor
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

6.  Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.

Authors:  Qiyue Ding; Nataliia V Shults; Sergiy G Gychka; Brent T Harris; Yuichiro J Suzuki
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

7.  Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease.

Authors:  Giuseppe Caruso; Margherita Grasso; Annamaria Fidilio; Sebastiano Alfio Torrisi; Nicolò Musso; Federica Geraci; Maria Rosaria Tropea; Anna Privitera; Fabio Tascedda; Daniela Puzzo; Salvatore Salomone; Filippo Drago; Gian Marco Leggio; Filippo Caraci
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

8.  Dietary patterns in middle age: effects on concurrent neurocognition and risk of age-related cognitive decline.

Authors:  Sarah Gauci; Lauren M Young; Lizanne Arnoldy; Annie-Claude Lassemillante; Andrew Scholey; Andrew Pipingas
Journal:  Nutr Rev       Date:  2022-04-08       Impact factor: 7.110

Review 9.  Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; George P Chrousos
Journal:  Mol Psychiatry       Date:  2020-04-30       Impact factor: 15.992

Review 10.  Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications.

Authors:  Yuda Turana; Michael Nathaniel; Robert Shen; Soegianto Ali; Rajender R Aparasu
Journal:  Brain Sci       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.